REFERENCES
1. Dai D, Rabinovitch PS, Ungvari Z. Mitochondria and cardiovascular aging. Circ Res. 2012;110:1109-24.
2. Ciumărnean L, Milaciu MV, Negrean V, et al. Cardiovascular risk factors and physical activity for the prevention of cardiovascular diseases in the elderly. Int J Environ Res Public Health. 2021;19:207.
3. Lesnefsky EJ, Chen Q, Hoppel CL. Mitochondrial metabolism in aging heart. Circ Res. 2016;118:1593-611.
4. Li Y, Jin X, Li D, et al. New insights into vascular aging: emerging role of mitochondria function. Biomed Pharmacother. 2022;156:113954.
5. Ding W, Chen J, Zhao L, Wu S, Chen X, Chen H. Mitochondrial DNA leakage triggers inflammation in age-related cardiovascular diseases. Front Cell Dev Biol. 2024;12:1287447.
6. Brown DA, Perry JB, Allen ME, et al. Mitochondrial function as a therapeutic target in heart failure. Nat Rev Cardiol. 2016;14:238-50.
7. Aon MA, Tocchetti CG, Bhatt N, Paolocci N, Cortassa S. Protective mechanisms of mitochondria and heart function in diabetes. Antioxid Redox Signal. 2015;22:1563-86.
8. Szeto HH, Liu S. Cardiolipin-targeted peptides rejuvenate mitochondrial function, remodel mitochondria, and promote tissue regeneration during aging. Arch Biochem Biophys. 2018;660:137-48.
9. Chatfield KC, Sparagna GC, Chau S, et al. Elamipretide improves mitochondrial function in the failing human heart. JACC Basic Transl Sci. 2019;4:147-57.
10. Ikeda Y, Sciarretta S, Nagarajan N, et al. New insights into the role of mitochondrial dynamics and autophagy during oxidative stress and aging in the heart. Oxid Med Cell Longev. 2014;2014:1-13.
11. Scheffer DDL, Garcia AA, Lee L, Mochly-rosen D, Ferreira JCB. Mitochondrial fusion, fission, and mitophagy in cardiac diseases: challenges and therapeutic opportunities. Antioxid Redox Signal. 2022;36:844-63.
12. Kirkman DL, Robinson AT, Rossman MJ, Seals DR, Edwards DG. Mitochondrial contributions to vascular endothelial dysfunction, arterial stiffness, and cardiovascular diseases. Am J Physiol Heart Circ Physiol. 2021;320:H2080-100.
13. Rouhi L, Gurha P, Marian AJ. The CGAS-STING1 pathway as a mediator of innate immune response in cardiovascular disease. JACC Asia. 2025;5:516-27.
14. López-otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: an expanding universe. Cell. 2023;186:243-78.
15. Lozhkin A, Vendrov AE, Ramos-mondragón R, et al. Mitochondrial oxidative stress contributes to diastolic dysfunction through impaired mitochondrial dynamics. Redox Biology. 2022;57:102474.
16. Chakravarti D, Labella KA, Depinho RA. Telomeres: history, health, and hallmarks of aging. Cell. 2021;184:306-22.
17. Guo J, Huang X, Dou L, et al. Aging and aging-related diseases: from molecular mechanisms to interventions and treatments. Sig Transduct Target Ther. 2022;7:391.
18. Ahmad D, Shila TA, Yang Y, Tan H, Wang Y. Current diagnostic modalities for detecting myocardial relaxation function in diabetes-associated heart failure or heart failure with preserved ejection fraction. Curr Opin Physiol. 2025;46:100863.
19. Viloria MAD, Li Q, Lu W, et al. Effect of exercise training on cardiac mitochondrial respiration, biogenesis, dynamics, and mitophagy in ischemic heart disease. Front Cardiovasc Med. 2022;9:949744.
20. Nair S, Ren J. Autophagy and cardiovascular aging: lesson learned from rapamycin. Cell Cycle. 2014;11:2092-9.
21. Barcena ML, Aslam M, Norman K, Ott C, Ladilov Y. Role of AMPK and sirtuins in aging heart: basic and translational aspects. Aging Dis. 2024;16:3335-60.
22. Wu S, Zou M. AMPK, mitochondrial function, and cardiovascular disease. Int J Mol Sci. 2020;21:4987.
23. Faitg J, D’amico D, Rinsch C, Singh A. Mitophagy activation by urolithin a to target muscle aging. Calcif Tissue Int. 2023;114:53-9.
24. Glancy B, Kim Y, Katti P, Willingham TB. The functional impact of mitochondrial structure across subcellular scales. Front Physiol. 2020;11:541040.
25. Kurz FT, Aon MA, O’rourke B, Armoundas AA. Cardiac mitochondria exhibit dynamic functional clustering. Front Physiol. 2014;5:1-8.
26. Jiang Z, Shen T, Huynh H, Fang X, Han Z, Ouyang K. Cardiolipin regulates mitochondrial ultrastructure and function in mammalian cells. Genes. 2022;13:1889.
27. Kurz FT, Derungs T, Aon MA, O’rourke B, Armoundas AA. Mitochondrial networks in cardiac myocytes reveal dynamic coupling behavior. Biophys J. 2015;108:1922-33.
28. Aon MA, Cortassa S, O’rourke B. The fundamental organization of cardiac mitochondria as a network of coupled oscillators. Biophys J. 2006;91:4317-27.
29. Ali MA, Gioscia-ryan R, Yang D, Sutton NR, Tyrrell DJ. Cardiovascular aging: spotlight on mitochondria. Am J Physiol Heart Circ Physiol. 2024;326:H317-33.
30. Padrão AI, Ferreira RM, Vitorino R, et al. OXPHOS susceptibility to oxidative modifications: the role of heart mitochondrial subcellular location. Biochim Biophys Acta Bioenerg. 2011;1807:1106-13.
31. Kasumov T, Dabkowski ER, Shekar KC, et al. Assessment of cardiac proteome dynamics with heavy water: slower protein synthesis rates in interfibrillar than subsarcolemmal mitochondria. Am J Physiol Heart Circ Physiol. 2013;304:H1201-14.
32. Kluge MA, Fetterman JL, Vita JA. Mitochondria and endothelial function. Circ Res. 2013;112:1171-88.
33. Tracy EP, Hughes W, Beare JE, Rowe G, Beyer A, Leblanc AJ. Aging-induced impairment of vascular function: mitochondrial redox contributions and physiological/clinical implications. Antioxid Redox Signal. 2021;35:974-1015.
34. Xu X, Pang Y, Fan X. Mitochondria in oxidative stress, inflammation and aging: from mechanisms to therapeutic advances. Sig Transduct Target Ther. 2025;10:190.
35. Chen J, Zhong J, Wang L, Chen Y. Mitochondrial transfer in cardiovascular disease: from mechanisms to therapeutic implications. Front Cardiovasc Med. 2021;8:771298.
36. Iorio R, Petricca S, Di Emidio G, Falone S, Tatone C. Mitochondrial extracellular vesicles (mitoEVs): emerging mediators of cell-to-cell communication in health, aging and age-related diseases. Ageing Res Rev. 2024;101:102522.
37. Wu S, Yang T, Ma M, et al. Extracellular vesicles meet mitochondria: potential roles in regenerative medicine. Pharmacol Res. 2024;206:107307.
38. Zhang Y, Yu Z, Jiang D, et al. iPSC-MSCs with high intrinsic MIRO1 and sensitivity to TNF-α yield efficacious mitochondrial transfer to rescue anthracycline-induced cardiomyopathy. Stem Cell Reports. 2016;7:749-63.
39. Liu K, Ji K, Guo L, et al. Mesenchymal stem cells rescue injured endothelial cells in an in vitro ischemia-reperfusion model via tunneling nanotube like structure-mediated mitochondrial transfer. Microvasc Res. 2014;92:10-8.
40. Manickam DS, Pinky PP, Khare P. Extracellular vesicle-mediated mitochondria delivery: premise and promise. J Cereb Blood Flow Metab. 2025;46:306-21.
41. Nicolás-Ávila JA, Lechuga-vieco AV, Esteban-martínez L, et al. A network of macrophages supports mitochondrial homeostasis in the heart. Cell. 2020;183:94-109.e23.
42. O’brien CG, Ozen MO, Ikeda G, et al. Mitochondria-rich extracellular vesicles rescue patient-specific cardiomyocytes from doxorubicin injury: insights into the SENECA trial. JACC CardioOncology. 2021;3:428-40.
43. Ikeda G, Santoso MR, Tada Y, et al. Mitochondria-rich extracellular vesicles from autologous stem cell-derived cardiomyocytes restore energetics of ischemic myocardium. J Am Coll Cardiol. 2021;77:1073-88.
44. Mone P, Agyapong ED, Morciano G, et al. Dysfunctional mitochondria elicit bioenergetic decline in the aged heart. J Cardiovasc Aging. 2024;4:13.
45. Sansbury BE, Jones SP, Riggs DW, Darley-usmar VM, Hill BG. Bioenergetic function in cardiovascular cells: the importance of the reserve capacity and its biological regulation. Chem Biol Interact. 2011;191:288-95.
46. Liang WJ, Gustafsson ÅB. The aging heart: mitophagy at the center of rejuvenation. Front Cardiovasc Med. 2020;7:18.
47. Gabillard-lefort C, Thibault T, Lenaers G, Wiesner RJ, Mialet-perez J, Baris OR. Heart of the matter: mitochondrial dynamics and genome alterations in cardiac aging. Mech Ageing Dev. 2025;224:112044.
48. Molina-Riquelme I, Barrientos G, Breitsprecher L, et al. Multi-scale mitochondrial cristae remodeling links Opa1 downregulation to reduced OXPHOS capacity in aged hearts. bioRxiv 2025. https://www.biorxiv.org/content/10.1101/2025.04.01.644555v1.abstract (accessed 2026-05-12).
49. Paradies G, Paradies V, Ruggiero FM, Petrosillo G. Role of cardiolipin in mitochondrial function and dynamics in health and disease: molecular and pharmacological aspects. Cells. 2019;8:728.
50. Kane AE, Sinclair DA. Sirtuins and NAD+ in the development and treatment of metabolic and cardiovascular diseases. Circ Res. 2018;123:868-85.
51. Yuan Y, Liang B, Liu X, et al. Targeting NAD+: is it a common strategy to delay heart aging? Cell Death Discov. 2022;8:230.
52. Zong Y, Li H, Liao P, et al. Mitochondrial dysfunction: mechanisms and advances in therapy. Sig Transduct Target Ther. 2024;9:124.
53. Chen W, Zhao H, Li Y. Mitochondrial dynamics in health and disease: mechanisms and potential targets. Sig Transduct Target Ther. 2023;8:333.
54. Hinton A, Claypool SM, Neikirk K, et al. Mitochondrial structure and function in human heart failure. Circ Res. 2024;135:372-96.
55. Saito T, Sadoshima J. Molecular mechanisms of mitochondrial autophagy/mitophagy in the heart. Circ Res. 2015;116:1477-90.
56. Xie S, Xu S, Deng W, Tang Q. Metabolic landscape in cardiac aging: insights into molecular biology and therapeutic implications. Sig Transduct Target Ther. 2023;8:114.
58. Shirihai OS, Song M, Dorn GW. How mitochondrial dynamism orchestrates mitophagy. Circ Res. 2015;116:1835-49.
59. Ajoolabady A, Aslkhodapasandhokmabad H, Aghanejad A, Zhang Y, Ren J. Mitophagy receptors and mediators: therapeutic targets in the management of cardiovascular ageing. Ageing Res Rev. 2020;62:101129.
60. Zhang R, Krigman J, Luo H, Ozgen S, Yang M, Sun N. Mitophagy in cardiovascular homeostasis. Mech Ageing Dev. 2020;188:111245.
61. Lampert MA, Orogo AM, Najor RH, et al. BNIP3L/NIX and FUNDC1-mediated mitophagy is required for mitochondrial network remodeling during cardiac progenitor cell differentiation. Autophagy. 2019;15:1182-98.
62. Shirakabe A, Ikeda Y, Sciarretta S, Zablocki DK, Sadoshima J. Aging and autophagy in the heart. Circ Res. 2016;118:1563-76.
63. Dutta D, Calvani R, Bernabei R, Leeuwenburgh C, Marzetti E. Contribution of impaired mitochondrial autophagy to cardiac aging: mechanisms and therapeutic opportunities. Circ Res. 2012;110:1125-38.
64. Aman Y, Schmauck-medina T, Hansen M, et al. Autophagy in healthy Aging Dis. Nat Aging. 2021;1:634-50.
65. Zhang C, Lin S. AMPK promotes autophagy by facilitating mitochondrial fission. Cell Metab. 2016;23:399-401.
66. Ikeda Y, Shirakabe A, Maejima Y, et al. Endogenous Drp1 mediates mitochondrial autophagy and protects the heart against energy stress. Circ Res. 2015;116:264-78.
67. Trouillard M, Meunier B, Rappaport F. Questioning the functional relevance of mitochondrial supercomplexes by time-resolved analysis of the respiratory chain. Proc Natl Acad Sci U S A. 2011;108:E1027-34.
69. Devin A, Rigoulet M. Mechanisms of mitochondrial response to variations in energy demand in eukaryotic cells. Am J Physiol Cell Physiol. 2007;292:C52-8.
70. Glancy B, Balaban RS. Role of mitochondrial Ca2+ in the regulation of cellular energetics. Biochemistry. 2012;51:2959-73.
71. Simmen T, Tagaya M. Organelle communication at membrane contact sites (MCS): from curiosity to center stage in cell biology and biomedical research. In: Tagaya M, Simmen T, Editors. Organelle Contact Sites. Singapore: Springer Singapore; 2017. pp. 1-12.
72. Szabadkai G, Bianchi K, Várnai P, et al. Chaperone-mediated coupling of endoplasmic reticulum and mitochondrial Ca2+ channels. J Cell Biol. 2006;175:901-11.
73. Soubannier V, Rippstein P, Kaufman BA, Shoubridge EA, Mcbride HM. Reconstitution of mitochondria derived vesicle formation demonstrates selective enrichment of oxidized cargo. PLoS ONE. 2012;7:e52830.
74. Todkar K, Chikhi L, Desjardins V, El-mortada F, Pépin G, Germain M. Selective packaging of mitochondrial proteins into extracellular vesicles prevents the release of mitochondrial DAMPs. Nat Commun. 2021;12:1971.
75. Schvartzman JM, Thompson CB, Finley LW. Metabolic regulation of chromatin modifications and gene expression. J Cell Biol. 2018;217:2247-59.
76. Fessler E, Eckl E, Schmitt S, et al. A pathway coordinated by DELE1 relays mitochondrial stress to the cytosol. Nature. 2020;579:433-7.
77. Oduro PK, Zheng X, Wei J, et al. The cGAS-STING signaling in cardiovascular and metabolic diseases: future novel target option for pharmacotherapy. Acta Pharm Sin B. 2022;12:50-75.
78. Stephens OR, Grant D, Frimel M, et al. Characterization and origins of cell-free mitochondria in healthy murine and human blood. Mitochondrion. 2020;54:102-12.
79. Nakahira K, Kyung S, Rogers AJ, et al. Circulating mitochondrial DNA in patients in the ICU as a marker of mortality: derivation and validation. PLoS Med. 2013;10:e1001577.
80. Jena J, García-peña LM, Pereira RO. The roles of FGF21 and GDF15 in mediating the mitochondrial integrated stress response. Front Endocrinol. 2023;14:1264530.
81. Amersfoort J, Eelen G, Carmeliet P. Immunomodulation by endothelial cells - partnering up with the immune system? Nat Rev Immunol. 2022;22:576-88.
82. Widlansky ME, Gutterman DD. Regulation of endothelial function by mitochondrial reactive oxygen species. Antioxid Redox Signal. 2011;15:1517-30.
83. Kempf S, Popp R, Naeem Z, et al. Pericyte-to-endothelial cell communication via tunneling nanotubes is disrupted by a diol of docosahexaenoic acid. Cells. 2024;13:1429.
84. Nguyen TT, Wei S, Nguyen TH, et al. Mitochondria-associated programmed cell death as a therapeutic target for age-related disease. Exp Mol Med. 2023;55:1595-619.
85. Burtscher J, Soltany A, Visavadiya NP, et al. Mitochondrial stress and mitokines in aging. Aging Cell. 2023;22:e13770.
86. Yu H, Liao K, Hu Y, et al. Role of the cGAS-STING pathway in aging-related endothelial dysfunction. Aging Dis. 2022;13:1901.
87. Dikalov SI, Ungvari Z. Role of mitochondrial oxidative stress in hypertension. Am J Physiol Heart Circ Physiol. 2013;305:H1417-27.
88. Higashi Y, Kihara Y, Noma K. Endothelial dysfunction and hypertension in aging. Hypertens Res. 2012;35:1039-47.
89. Chang X, Li Y, Cai C, et al. Mitochondrial quality control mechanisms as molecular targets in diabetic heart. Metabolism. 2022;137:155313.
90. Liu S, D’amico D, Shankland E, et al. Effect of urolithin a supplementation on muscle endurance and mitochondrial health in older adults: a randomized clinical trial. JAMA Netw Open. 2022;5:e2144279.
91. Lin Y, Zeidan RS, Lapierre-nguyen S, et al. Nicotinamide riboside combined with exercise to treat hypertension in middle-aged and older adults: a pilot randomized clinical trial. GeroScience. 2025;47:6895-908.
92. Da C. Pinaffi-langley AC, Szarvas Z, Peterfi A, et al. Time-restricted eating for prevention of age-related vascular cognitive decline in older adults: a protocol for a single-arm open-label interventional trial. PLoS ONE. 2024;19:e0314871.
94. Mone P, Varzideh F, Jankauskas SS, et al. SGLT2 inhibition via empagliflozin improves endothelial function and reduces mitochondrial oxidative stress: insights from frail hypertensive and diabetic patients. Hypertension. 2022;79:1633-43.
95. Cook NR. A randomized factorial trial of vitamins c and e and beta carotene in the secondary prevention of cardiovascular events in women: results from the women’s antioxidant cardiovascular study. Arch Intern Med. 2007;167:1610.
96. Jiang Q, Yin J, Chen J, et al. Mitochondria-targeted antioxidants: a step towards disease treatment. Oxid Med Cell Longev. 2020;2020:1-18.
97. Graham D, Huynh NN, Hamilton CA, et al. Mitochondria-targeted antioxidant MitoQ10 improves endothelial function and attenuates cardiac hypertrophy. Hypertension. 2009;54:322-8.
98. Singh A, D’amico D, Andreux PA, et al. Urolithin a improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults. Cell Reports Medicine. 2022;3:100633.
99. Desler C, Hansen TL, Frederiksen JB, Marcker ML, Singh KK, Juel Rasmussen L. Is there a link between mitochondrial reserve respiratory capacity and aging? J Aging Res. 2012;2012:1-9.
100. Fernandez-sanz C, Ruiz-meana M, Miro-casas E, et al. Defective sarcoplasmic reticulum-mitochondria calcium exchange in aged mouse myocardium. Cell Death Dis. 2014;5:e1573.
101. Moghaddas S, Hoppel CL, Lesnefsky EJ. Aging defect at the QO site of complex III augments oxyradical production in rat heart interfibrillar mitochondria. Arch Biochem Biophys. 2003;414:59-66.
102. Hofer T, Servais S, Seo AY, et al. Bioenergetics and permeability transition pore opening in heart subsarcolemmal and interfibrillar mitochondria: effects of aging and lifelong calorie restriction. Mech Ageing Dev. 2009;130:297-307.
103. Wikström M, Springett R. Thermodynamic efficiency, reversibility, and degree of coupling in energy conservation by the mitochondrial respiratory chain. Commun Biol. 2020;3:451.
104. Dudek J, Hartmann M, Rehling P. The role of mitochondrial cardiolipin in heart function and its implication in cardiac disease. Biochim Biophys Acta Mol Basis Dis. 2019;1865:810-21.
105. Popoiu T, Maack C, Bertero E. Mitochondrial calcium signaling and redox homeostasis in cardiac health and disease. Front Mol Med. 2023;3:1235188.
106. Davies KM, Strauss M, Daum B, et al. Macromolecular organization of ATP synthase and complex I in whole mitochondria. Proc Natl Acad Sci U S A. 2011;108:14121-6.
107. Strauss M, Hofhaus G, Schröder RR, Kühlbrandt W. Dimer ribbons of ATP synthase shape the inner mitochondrial membrane. EMBO J. 2008;27:1154-60.
108. Quintana-cabrera R, Quirin C, Glytsou C, et al. The cristae modulator Optic atrophy 1 requires mitochondrial ATP synthase oligomers to safeguard mitochondrial function. Nat Commun. 2018;9:3399.
110. Zhang M, Mileykovskaya E, Dowhan W. Cardiolipin is essential for organization of complexes III and IV into a supercomplex in intact yeast mitochondria. J Biol Chem. 2005;280:29403-8.
111. Lesnefsky EJ, Hoppel CL. Cardiolipin as an oxidative target in cardiac mitochondria in the aged rat. Biochim Biophys Acta Bioenerg. 2008;1777:1020-7.
112. Du J, Yu Q, Anjorin OE, Wang M. Age-related mitochondrial alterations contribute to myocardial responses during sepsis. Cells. 2025;14:1221.
113. Gherardi G, Monticelli H, Rizzuto R, Mammucari C. The mitochondrial Ca2+ uptake and the fine-tuning of aerobic metabolism. Front Physiol. 2020;11:554904.
114. Mather M, Rottenberg H. Aging enhances the activation of the permeability transition pore in mitochondria. Biochem Biophys Res Commun. 2000;273:603-8.
115. Bertero E, Nickel A, Kohlhaas M, et al. Loss of mitochondrial Ca2+ uniporter limits inotropic reserve and provides trigger and substrate for arrhythmias in Barth syndrome cardiomyopathy. Circulation. 2021;144:1694-713.
116. Yan X, Wang R, Xu H, Tao Z, Ling J. The mechanisms associated with inflammation and coronary microvascular dysfunction in heart failure with preserved ejection fraction. Med Princ Pract. 2025;35:101-13.
117. Patyal P, Azhar G, Verma A, et al. Mitochondrial dynamics in aging heart. Biomedicines. 2025;13:2603.
118. Vásquez‐trincado C, García‐carvajal I, Pennanen C, et al. Mitochondrial dynamics, mitophagy and cardiovascular disease. J Physiol. 2016;594:509-25.
119. Nakayama H, Otsu K. Mitochondrial DNA as an inflammatory mediator in cardiovascular diseases. Biochem J. 2018;475:839-52.
120. Guerrero-navarro L, Jansen-dürr P, Cavinato M. Age-related lysosomal dysfunctions. Cells. 2022;11:1977.
121. Rodríguez-nuevo A, Zorzano A. The sensing of mitochondrial DAMPs by non-immune cells. Cell Stress. 2019;3:195-207.
122. Grazioli S, Pugin J. Mitochondrial damage-associated molecular patterns: from inflammatory signaling to human diseases. Front Immunol. 2018;9:832.
123. Chen S, Liao Z, Xu P. Mitochondrial control of innate immune responses. Front Immunol. 2023;14:1166214.
124. Zhang B, Chang JY, Lee MH, Ju S, Yi H, Shong M. Mitochondrial stress and mitokines: therapeutic perspectives for the treatment of metabolic diseases. Diabetes Metab J. 2024;48:1-18.
125. Konerman MC, Greenberg JC, Kolias TJ, et al. Reduced myocardial flow reserve is associated with diastolic dysfunction and decreased left atrial strain in patients with normal ejection fraction and epicardial perfusion. J Card Fail. 2018;24:90-100.
126. Janaszak-jasiecka A, Płoska A, Wierońska JM, Dobrucki LW, Kalinowski L. Endothelial dysfunction due to eNOS uncoupling: molecular mechanisms as potential therapeutic targets. Cell Mol Biol Lett. 2023;28:21.
127. Lipowsky HH. The endothelial glycocalyx as a barrier to leukocyte adhesion and its mediation by extracellular proteases. Ann Biomed Eng. 2011;40:840-8.
128. Lagrange J, Jahangiri M, Baudry G, et al. Association between endothelial alterations, cardiac function, and outcomes from health to heart failure: insight from the STANISLAS, MEDIA‐DHF, and BIOSTAT‐CHF cohorts. J Am Hear Assoc. 2025;14:e040179.
129. Aldiwani H, Nelson MD, Sharif B, et al. Reduced myocardial perfusion is common among subjects with ischemia and no obstructive coronary artery disease and heart failure with preserved ejection fraction: a report from the WISE-CVD continuation study. Vessel Plus. 2022;6:16.
130. Su H, Cantrell AC, Zeng H, Zhu S, Chen J. Emerging role of pericytes and their secretome in the heart. Cells. 2021;10:548.
131. Armulik A, Genové G, Mäe M, et al. Pericytes regulate the blood-brain barrier. Nature. 2010;468:557-61.
132. O'farrell FM, Mastitskaya S, Hammond-haley M, Freitas F, Wah WR, Attwell D. Capillary pericytes mediate coronary no-reflow after myocardial ischaemia. eLife. 2017;6:e29280.
133. Simmonds SJ, Grootaert MOJ, Cuijpers I, et al. Pericyte loss initiates microvascular dysfunction in the development of diastolic dysfunction. Eur Heart J Open. 2024;4:oead129.
134. Das A, Huang GX, Bonkowski MS, et al. Impairment of an endothelial NAD+-H2S signaling network is a reversible cause of vascular aging. Cell. 2018;173:74-89.e20.
135. Grossini E, Venkatesan S, Ola Pour MM. Mitochondrial dysfunction in endothelial cells: a key driver of organ disorders and aging. Antioxidants. 2025;14:372.
136. Han Q, Yu Y, Liu X, et al. The Role of endothelial cell mitophagy in age-related cardiovascular diseases. Aging Dis. 2025;16:2151.
137. Csiszar A, Tarantini S, Yabluchanskiy A, et al. Role of endothelial NAD+ deficiency in age-related vascular dysfunction. Am J Physiol Heart Circ Physiol. 2019;316:H1253-66.
138. Sinha A, Rahman H, Webb A, Shah AM, Perera D. Untangling the pathophysiologic link between coronary microvascular dysfunction and heart failure with preserved ejection fraction. Eur Heart J. 2021;42:4431-41.
139. Huang LS, Hong Z, Wu W, et al. mtDNA activates cGAS signaling and suppresses the YAP-mediated endothelial cell proliferation program to promote inflammatory injury. Immunity. 2020;52:475-486.e5.
140. Singh M, Jhajharia A, Pruthi R, Carmichael OT. 31P‐MRS‐measured phosphocreatine recovery kinetics in human muscles in health and disease-a systematic review and Meta‐analysis. NMR Biomed. 2025;38:e70023.
141. Georgakoudi I, Quinn KP. Label-free optical metabolic imaging in cells and tissues. Annu Rev Biomed Eng. 2023;25:413-43.
142. Chacko BK, Kramer PA, Ravi S, et al. Methods for defining distinct bioenergetic profiles in platelets, lymphocytes, monocytes, and neutrophils, and the oxidative burst from human blood. Lab Investig. 2013;93:690-700.
143. Trumpff C, Michelson J, Lagranha CJ, et al. Stress and circulating cell-free mitochondrial DNA: a systematic review of human studies, physiological considerations, and technical recommendations. Mitochondrion. 2021;59:225-45.
144. Miotto PM, Mcglory C, Holloway TM, Phillips SM, Holloway GP. Sex differences in mitochondrial respiratory function in human skeletal muscle. Am J Physiol Regul Integr Comp Physiol. 2018;314:R909-15.
145. De Goede P, Wefers J, Brombacher EC, Schrauwen P, Kalsbeek A. Circadian rhythms in mitochondrial respiration. J Mol Endocrinol. 2018;60:R115-30.
146. Liu D, Li H, Lu J, Bai Y. Tissue-specific implications of mitochondrial alterations in aging. Front Biosci. 2013;E5:734-47.
147. Thijssen DHJ, Bruno RM, Van Mil ACCM, et al. Expert consensus and evidence-based recommendations for the assessment of flow-mediated dilation in humans. Eur Heart J. 2019;40:2534-47.
148. Pence BD, Yarbro JR. Aging impairs mitochondrial respiratory capacity in classical monocytes. Exp Gerontol. 2018;108:112-7.
149. Georgakoudi I, Skala MC, Quinn KP, et al. Consensus guidelines for cellular label-free optical metabolic imaging: ensuring accuracy and reproducibility in metabolic profiling. J Biomed Opt. 2025;30:S23901-S23901.
150. Pfeiffer K, Gohil V, Stuart RA, et al. Cardiolipin stabilizes respiratory chain supercomplexes. J Biol Chem. 2003;278:52873-80.
151. Panel M, Ghaleh B, Morin D. Mitochondria and aging: a role for the mitochondrial transition pore? Aging Cell. 2018;17:e12793.
152. Sindler AL, Delp MD, Reyes R, Wu G, Muller‐delp JM. Effects of ageing and exercise training on eNOS uncoupling in skeletal muscle resistance arterioles. J Physiol. 2009;587:3885-97.
153. Liang W, Sagar S, Ravindran R, et al. Mitochondria are secreted in extracellular vesicles when lysosomal function is impaired. Nat Commun. 2023;14:5031.
154. Kim J, Kim H, Chung JH. Molecular mechanisms of mitochondrial DNA release and activation of the cGAS-STING pathway. Exp Mol Med. 2023;55:510-9.
155. Seals D, Murphy M, Gioscia-Ryan R, et al. Chronic supplementation with a mitochondrial antioxidant (MitoQ) improves vascular function in healthy older adults. Hypertension. 2018;71:1056-63.
157. Dorn GW. Mitochondrial pruning by nix and BNip3: an essential function for cardiac-expressed death factors. J Cardiovasc Transl Res. 2010;3:374-83.
158. Titus AS, Sung E, Zablocki D, Sadoshima J. Mitophagy for cardioprotection. Basic Res Cardiol. 2023;118:42.
